Concepedia

Author

David Borg

Lund UniversityORCID

Also Known As

C Michaux, C Vella, D. Borg, D., Borg, D.E. BORG, David Borg, E Pllaha, R.G. Xuereb, T Piscopo, T. Piscopo

53

Publications

4.8K

Citations

21

H-Index

6

Concepts

All Affiliations

Lund UniversitySkåne University HospitalUppsala UniversityKarolinska InstitutetClatterbridge Cancer Centre NHS Foundation Trust
DB

About

David Borg is an author at Lund University specializing in surgical oncology, radiation oncology, and surgery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

562

2

Gastroenterology

1

1

562

3

Surgical Oncology

1

1

562

4

Oncology

1

1

562

5

Radiation Oncology

1

1

562

David Borg

×

19

Publications

3.3K

Citations

17

H-Index

YearCitations

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

John P. Neoptolemos, Daniel H. Palmer, Paula Ghaneh,

The Lancet

2017

1.9K

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken,

The Lancet Oncology

2018

562

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma

Robert Jones, Eftychia‐Eirini Psarelli, Richard Jackson,

JAMA Surgery

2019

256

Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma

Richard Fristedt, David Borg, Charlotta Hedner,

Journal of Gastrointestinal Oncology

2016

74

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Artur Mezheyeuski, Max Backman, Johanna Sofia Margareta Mattsson,

EBioMedicine

2023

72

The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma

Maria Svensson, Carl Fredrik Warfvinge, Richard Fristedt,

Oncotarget

2017

62

The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types

Patrick Micke, Carina Strell, Johanna Sofia Margareta Mattsson,

EBioMedicine

2021

58

Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial

Klara Nilsson, Fredrik Klevebro, Berit Sunde,

Annals of Oncology

2023

53

Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival

Maria Svensson, David Borg, Cheng Zhang,

Frontiers in Oncology

2019

44

Tumor-Associated CD68+, CD163+, and MARCO+ Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma

Martin Jeremiasen, David Borg, Charlotta Hedner,

Frontiers in Oncology

2020

41

Page 1